Arcutis Reports 2026 Revenue of $143.92 Million and Net Income of $8.8 Million
Revenue rose 45.1% year over year, net income increased 18.8%, and diluted EPS was $0.06, unchanged from the prior-year period.
Arcutis Biotherapeutics reported 2026 results with revenue of $143.92 million, up 45.1% year over year, and net income of $8.8 million, up 18.8%. Diluted EPS was $0.06, unchanged from the prior-year period.Financial Highlights¹ Reported as “Product revenue, net”. ² Reported as “Net income (loss)”…